Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PAS-004 |
Synonyms | |
Therapy Description |
PAS-004 inhibits MEK, which potentially decreases downstream signaling and proliferation (Cancer Res (2011) 71 (8_Supplement): 5470). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PAS-004 | PAS004|PAS 004|CIP-137401|CIP-1374 | MEK1 Inhibitor 26 MEK2 Inhibitor 24 | PAS-004 inhibits MEK, which potentially decreases downstream signaling and proliferation (Cancer Res (2011) 71 (8_Supplement): 5470). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06299839 | Phase I | PAS-004 | PAS-004 in Patients With Advanced Solid Tumors | Recruiting | USA | ROU | BGR | 0 |